NEW YORK — Pfizer and BioNTech are making a strong case for the authorization of a third or booster dose of the companies’ Covid-19, for which they have submitted the phase I data of clinical trials evaluating the safety and immunogenicity of the dose. The data will also be submitted to the European Medicines Agency and other regulatory authorities in the coming […]
The post Pfizer, BioNTech Expecting Phase III Trial Results For Booster Dose first appeared on The Florida Star | The Georgia Star.
